Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Split-Face, Randomized, Placebo-Controlled, Double-Blind Study to Investigate Passive Versus Active Dermal Filler Administration
Publication

Publications

Split-Face, Randomized, Placebo-Controlled, Double-Blind Study to Investigate Passive Versus Active Dermal Filler Administration

Title
Split-Face, Randomized, Placebo-Controlled, Double-Blind Study to Investigate Passive Versus Active Dermal Filler Administration
Type
Article in International Scientific Journal
Year
2018
Authors
Freire dos Santos, MJF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fontes-Carvalho R
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Arnaut, LG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 42
Pages: 1655-1663
ISSN: 0364-216X
Publisher: Springer Nature
Other information
Authenticus ID: P-00P-ECB
Resumo (PT):
Abstract (EN): Background QueryHyaluronic acid (HA) is a large polymer increasingly used as dermal filler. HA does not permeate through healthy skin and is administered using various injection techniques. As HA procedures become more popular, the number of complications in facial rejuvenation procedures is likely to increase. Alternative methods may be necessary to satisfy the increasing demand for HA procedures. High-frequency high-intensity ultrasound is a painless and noninvasive method to deliver large molecules to the skin that is expected to deliver HA with visible results. Objective Assess facial rejuvenation with HA delivered with high-frequency high-intensity ultrasound. Methods Fifteen women (mean age 55) willing to participate in a randomized, double-blind, face-split trial with HA and placebo formulations in different sides of the face, were subject to five treatment sessions with high-frequency high-intensity ultrasound. Photographs taken before the procedure and after the last procedure were evaluated by a panel of five experts, blind to which side was treated with the HA or with the placebo. Results The expert panel identified a noticeable facial rejuvenation in the HA side relative to the placebo with a very statistically significant difference between the two sides (p < 0.0001). Conclusions Administration of HA with high-frequency high-intensity ultrasound is safe and leads to unambiguous facial rejuvenation.
Language: English
Type (Professor's evaluation): Dissemination
No. of pages: 9
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Use of Doppler in Breast Reduction with Superomedial or Superolateral Pedicles (2010)
Another Publication in an International Scientific Journal
Horta, R; Silva, P; Filipe, R; Costa, J; Bartosh, I; Amarante J; Silva, A
Herpes Zoster infection after trunk liposuction (2022)
Another Publication in an International Scientific Journal
Horta, R; Frias, F; Carvalho, F
Tuberous breast: A surgical challenge (2002)
Article in International Scientific Journal
Choupina, M; Malheiro, E; Pinho, C; Costa-Ferreira A; Pinto, A; Cardoso, A; Reis, J; Amarante J
The tuberous breast – a surgical challenge. (2002)
Article in International Scientific Journal
Choupina M; Malheiro E; Pinho C; Costa-Ferreira A; Pinto A; Cardoso A; Reis J; Amarante J
The "PIP Problem": Clinical and Histologic Characteristics (2013)
Article in International Scientific Journal
Correia Sa, I; Rodrigues Pereira, P; Marisa Marques

See all (13)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-21 at 21:22:03 | Privacy Policy | Personal Data Protection Policy | Whistleblowing